Evaluation of Antibiotic Resistance Patterns and Trends among Patients at Selected Secondary Healthcare Facilities in Taraba State, Nigeria (2019–2023)

Background: Antimicrobial resistance is a growing global public health challenge, disproportionately affecting low- and middle-income countries such as Nigeria, where surveillance and antimicrobial stewardship systems remain limited, particularly at secondary healthcare levels.
Objective: This study evaluated antibiotic resistance patterns and temporal trends among bacterial isolates from patients attending selected secondary healthcare facilities in Taraba State, Nigeria, between 2019 and 2023.
Methods: A retrospective cross-sectional study was conducted using microbiology laboratory records from three secondary healthcare facilities between January 2019 and December 2023. Data on patient demographics, specimen types, bacterial isolates, and antibiotic susceptibility test results were extracted and analysed using descriptive statistics.
Results: A total of 2,057 patient samples were analysed, with females accounting for 55.1% and adults for 51.6% of cases. Urine (32.0%) and high vaginal swabs (21.6%) were the most common specimens. Overall antimicrobial resistance was 72.0%. High resistance rates were observed among coliforms (98.9%) and Proteus species (94.9%). Significant inter-facility variation was noted, with the highest resistance recorded at General Hospital Gembu (97.4%). Resistance peaked in 2019 and declined to 65.5% in 2023.
Conclusion: Antimicrobial resistance remains alarmingly high in secondary healthcare facilities in Taraba State, with notable temporal and facility-level variations. Strengthening antimicrobial stewardship, laboratory capacity, and routine surveillance is urgently required.
What this study adds: This study provides multi-year antimicrobial resistance data from secondary healthcare facilities in northeastern Nigeria, highlighting facility-specific patterns and temporal trends to inform targeted antimicrobial stewardship and infection prevention strategies.

Antimicrobial resistance; Antibiotic susceptibility; Bacterial isolates; Secondary healthcare; Nigeria; Laboratory surveillance

1. Gandra S, Mojica N, Klein EY, Ashok A, Nerurkar V, Kumari M, Ramesh U, Dey S, Vadwai V, Das BR, Laxminarayan R. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014. Int J Infect Dis 2016;50:75-82. [Google Scholar] [Crossref]

2. World Health Organization. Antimicrobial resistance. Geneva: WHO; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed Sept 30, 2025. [Google Scholar] [Crossref]

3. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399(10325):629-55. [Google Scholar] [Crossref]

4. Egwuenu A, Ejikeme A, Tomczyk S, von Laer A, Ayobami O, Odebajo O, Akhibi S, Agulanna C, Osagie O, Inweregbu US, Yahaya R, Okwor T, Dada-Adegbola H, Ajayi I, Olorukooba A, Eckmanns T, Ochu CL, Ihekweazu C. Baseline study for improving diagnostic stewardship at secondary health care facilities in Nigeria. Antimicrob Resist Infect Control. 2022 May 3;11(1):65. [Google Scholar] [Crossref]

5. Ogunleye OO, Oyawole MR, Odunuga PT, Kalejaye F, Yinka-Ogunleye AF, Olalekan A, Ogundele SO, Ebruke BE, Kalada Richard A, Anand Paramadhas BD, Kurdi A, Sneddon J, Seaton A, Godman B. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications. Expert Rev Anti Infect Ther. 2022;20(2):297-306. [Google Scholar] [Crossref]

6. Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K. Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat. 2011;14(2):95-106. [Google Scholar] [Crossref]

7. Chukwu EE, Awoderu OB, Enwuru CA, Afocha EE, Lawal RG, Ahmed RA, Olanrewaju I, Onwuamah CK, Audu RA, Ogunsola FT. High prevalence of resistance to third-generation cephalosporins detected among clinical isolates from sentinel healthcare facilities in Lagos, Nigeria. Antimicrob Resist Infect Control. 2022 No;11(1):134. [Google Scholar] [Crossref]

8. Abubakar U, Sulaiman SAS. Prevalence, trend and antimicrobial susceptibility of Methicillin Resistant Staphylococcus aureus in Nigeria: a systematic review. J Infect Public Health. 2018;11(6):763-770. [Google Scholar] [Crossref]

9. Adamu H, Njoku K, Olajide I, Ukponu W, Niyang M. Antimicrobial resistance pattern across two states in Nigeria – a descriptive/observational study. Int J Infect Dis 2020;101:45. [Google Scholar] [Crossref]

10. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228-41. [Google Scholar] [Crossref]

11. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199-1226. [Google Scholar] [Crossref]

12. Chukwu EE, Oladele DA, Enwuru CA, Afocha EE, Lawal RG, Ezeudu CC, Audu RA, Onwuamah CK, Ogunsola FT, Okeke IN. Antimicrobial resistance awareness and antibiotic prescribing behavior among healthcare workers in Nigeria: a national survey. BMC Infect Dis 2021;21:22. [Google Scholar] [Crossref]

13. World Health Organization. Nigeria: National Action Plan for Antimicrobial Resistance 2017–2022. Geneva: World Health Organization; 2017. Available from: https://www.who.int/publications/m/item/nigeria-national-action-plan-for-antimicrobial-resistance. Accessed September 1, 2025. [Google Scholar] [Crossref]

14. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310(20):2191–4. [Google Scholar] [Crossref]

15. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, Pablos-Mendez A, Klugman KP. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5(8):481-93. [Google Scholar] [Crossref]

16. Onah SI, Umar HJ. Appraising Nigeria's approach to combating antimicrobial resistance. Int J Health Plann Manage. 2024;39(2):556-562. [Google Scholar] [Crossref]

17. Gilham EL, Casale E, Hardy A, Ayeni AH, Sunyer E, Harris T, Feechan R, Heltmann A, Fawcett M, Hopkins S, Ashiru-Oredope D. Assessing the impact of a national social marketing campaign for antimicrobial resistance on public awareness, attitudes, and behaviour, and as a supportive tool for healthcare professionals, England, 2017 to 2019. Euro Surveill. 2023;28(47):2300100. [Google Scholar] [Crossref]

18. Fadare JO, Ogunleye O, Iliyasu G, Adeoti A, Schellack N, Engler D, Massele A, Godman B. Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: Findings and implications. J Glob Antimicrob Resist. 2019;17:132-136. [Google Scholar] [Crossref]

19. Fadeyi, A., Bolaji, B., Oyedepo, O., Adesiyun, O., Adeboye, M., Olanrewaju, T., Aderibigbe, A., Salami, A., Desalu, O., Fowotade, A., Nwabuisi, C., Akanbi II, A., Raheem, R. & Olalere, A. (2010). Methicilin Resistant Staphylococcus aureus Carriage amongst Healthcare Workers of the Critical Care Units in a Nigerian Hospital. American Journal of Infectious Diseases, 6(1), 18-23. https://doi.org/10.3844/ajidsp.2010.18.23 [Google Scholar] [Crossref]

20. World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. Geneva: World Health Organization; 2020. Available from: https://www.who.int/publications/i/item/9789240005587. Accessed Septemter 1, 2025 [Google Scholar] [Crossref]

21. Lliyasu G, Habib AG, Mohammad AB. Antimicrobial Susceptibility Pattern of Invasive Pneumococcal Isolates in North West Nigeria. J Glob Infect Dis. 2015;7(2):70-4. [Google Scholar] [Crossref]

22. Diop M, Bassoum O, Ndong A, Wone F, Ghogomu Tamouh A, Ndoye M, Youbong T, Mbacké Daffé SM, Radji RO, Gueye MW, Lakhe NA, Fall B, Ba PS, Faye A. Prevalence of multidrug-resistant bacteria in healthcare and community settings in West Africa: systematic review and meta-analysis. BMC Infect Dis. 2025 Feb 28;25(1):292. doi: 10.1186/s12879-025-10562-w. PMID: 40022011; PMCID: PMC11871699. [Google Scholar] [Crossref]

23. World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/9789240027336. Accessed September 1, 2025. [Google Scholar] [Crossref]

24. Ajibola O, Omisakin OA, Eze AA, Omoleke SA. Self-Medication with Antibiotics, Attitude and Knowledge of Antibiotic Resistance among Community Residents and Undergraduate Students in Northwest Nigeria. Diseases. 2018 Apr 27;6(2):32. doi: 10.3390/diseases6020032. PMID: 29702565; PMCID: PMC6023284. [Google Scholar] [Crossref]

25. Okolie OJ, Igwe U, Ismail SU, Ighodalo UL, Adukwu EC. Systematic review of surveillance systems for AMR in Africa. J Antimicrob Chemother. 2022;78(1):31-51. [Google Scholar] [Crossref]

26. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-18. [Google Scholar] [Crossref]

27. Akinyemi KO, Smith SI, Oyefolu AO, Coker AO. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health. 2005;119(4):321-7. [Google Scholar] [Crossref]

28. Bernabé KJ, Langendorf C, Ford N, Ronat JB, Murphy RA. Antimicrobial resistance in West Africa: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50(5):629-639. [Google Scholar] [Crossref]

29. Nigeria Centre for Disease Control and Prevention. National Action Plan for Antimicrobial Resistance 2024-2028. Abuja: Federal Ministry of Health and Social Welfare; 2024. [Accessed 2026 Apr 04]. [Google Scholar] [Crossref]

30. Pulcini C, Binda F, Lamkang AS, Trett A, Charani E, Goff DA, Harbarth S, Hinrichsen SL, Levy-Hara G, Mendelson M, Nathwani D, Gunturu R, Singh S, Srinivasan A, Thamlikitkul V, Thursky K, Vlieghe E, Wertheim H, Zeng M, Gandra S, Laxminarayan R. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Microbiol Infect. 2019;25(1):20-25. [Google Scholar] [Crossref]

31. Logan LK, Weinstein RA. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36. doi: 10.1093/infdis/jiw282. PMID: 28375512; PMCID: PMC5853342 [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar